Home – FAQs
Critical questions on receptor binding kinetics, metabolic pathways, and detection methodologies—answered by our pharmacology advisory board.
Ultra-high CB1 affinity (Ki=0.24 nM) and resistance to FAAH degradation → prolonged receptor occupancy (Nature Neuroscience, 2026).
1. LC-QTOF-MS with 0.03 ng/mL LLOQ in whole blood. Full SOP at 5cladba.health/detection-guide.
WHO Level 2 PPE (nitrile gloves, respirator) + fume hood mandatory. Purity verification required pre-use.
Only Phase 0 microdosing studies with IRB/IACUC approval. 5CL-ADBA is for laboratory use.
Procurement guidelines for precursors, reference standards, and synthesis kits—with compliance documentation protocols.
Demand batch-specific qNMR reports (not HPLC-only). Our materials include triple-validation certificates.
End-Use Certificate + importer's research license. We handle UN documentation and customs pre-clearance.
IRB exemption for teaching labs. Kit protocols exclude controlled final compounds.
Yes—for non-controlled variants. Lead time: 3 weeks. Submit RFQ to WhatsApp: +852-9841-2493.
